It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The genome of Mycobacterium tuberculosis encodes for a large repertoire of toxin-antitoxin systems. In the present study, MenT3 and MenT4 toxins belonging to MenAT subfamily of TA systems have been functionally characterized. We demonstrate that ectopic expression of these toxins inhibits bacterial growth and this is rescued upon co-expression of their cognate antitoxins. Here, we show that simultaneous deletion of menT3 and menT4 results in enhanced susceptibility of M. tuberculosis upon exposure to oxidative stress and attenuated growth in guinea pigs and mice. We observed reduced expression of transcripts encoding for proteins that are essential or required for intracellular growth in mid-log phase cultures of ΔmenT4ΔT3 compared to parental strain. Further, the transcript levels of proteins involved in efficient bacterial clearance were increased in lung tissues of ΔmenT4ΔT3 infected mice relative to parental strain infected mice. We show that immunization of mice and guinea pigs with ΔmenT4ΔT3 confers significant protection against M. tuberculosis infection. Remarkably, immunization of mice with ΔmenT4ΔT3 results in increased antigen-specific TH1 bias and activated memory T cell response. We conclude that MenT3 and MenT4 are important for M. tuberculosis pathogenicity and strains lacking menT3 and menT4 have the potential to be explored further as vaccine candidates.
Gosain et al.’s work aims to enhance understanding of the contribution of MenT3 and MenT4 toxins belonging to MenAT TA systems to the physiology and pathogenesis of Mycobacterium tuberculosis. The authors show that strains lacking these proteins is attenuated and confers protection in vivo.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 NCR Biotech Science Cluster, Centre for Tuberculosis Research, Translational Health Sciences and Technology Institute, Faridabad, India (GRID:grid.464764.3) (ISNI:0000 0004 1763 2258)
2 NCR Biotech Science Cluster, Centre for Immunobiology and Immunotherapy, Translational Health Sciences and Technology Institute, Faridabad, India (GRID:grid.464764.3) (ISNI:0000 0004 1763 2258)
3 Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), Structural Biology Laboratory, Chandigarh, India (GRID:grid.417641.1) (ISNI:0000 0004 0504 3165)